BELLEROPHON THERAPEUTICS INC (BLPH)

US0787713009 - Common Stock

0.1025  -0.28 (-73.39%)

After market: 0.114 +0.01 (+11.22%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

 TTM
(2023-6-30)		 2022
(2022-12-31)		 2021
(2021-12-31)		 2020
(2020-12-31)		 2019
(2019-12-31)
CASH FLOWS FROM OPERATING ACTIVITIES
Net Income
-12.40M-19.83M-17.76M-24.73M-13.27M
Depreciation Amortization
27.00K65.00K102.00K150.00K350.00K
Change In Working Capital
582.00K1.21M-5.69M2.44M-160.00K
Other non cash items
775.00K785.00K526.00K2.26M140.00K
OPERATING CASH FLOW
-11.02M-17.77M-22.82M-19.88M-12.94M
 
CASH FLOWS FROM INVESTING ACTIVITIES
Capital Expenditure
N/AN/AN/AN/AN/A
Other Investing Activity
N/AN/AN/A0.000.00
INVESTING CASH FLOW
N/AN/AN/A0.000.00
 
CASH FLOWS FROM FINANCING ACTIVITIES
Stock Issued/Repurchased
N/A0.00N/A57.75M6.24M
Other Financing Activity
N/A-40.00KN/A-190.00K-70.00K
FINANCING CASH FLOW
N/A-40.00KN/A57.57M6.17M
 
CHANGE IN CASH
-6.05M-17.81M-22.82M37.69M-6.77M
 
FREE CASH FLOW
Operating Cash Flow
-11.02M-17.77M-22.82M-19.88M-12.94M
Capital Expenditure
N/AN/AN/AN/AN/A
FREE CASH FLOW
-11.02M-17.77M-22.82M-19.88M-12.94M

All data in USD

Charts